MedTrace Logo

Efficacy of Vitamin C Supplement vs Spinal Manipulation to Treatment in Lateral Epicondylitis

NCT04445727 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2020-06-26

No results posted yet for this study

Summary

A randomized clinical trial will be conducted. 130 subjects diagnosed with lateral epicondylitis will be studied. 3 intervention groups will be formed. Experimental group 1 will receive a 1000mg daily vitamin C supplement along with the usual practice of manual therapy and TENS. Group 2 will undergo high-speed vertebral manipulations along with manual therapy and TENS. In group 3 or control, manual therapy and transcutaneous electrotherapy (TENS) will be applied. All groups will receive the same manual therapy program and TENS, one session per week for 6 consecutive weeks. Data analysis: The data will be entered in the SPSS statistical package (version 21.0) for analysis). Statistical analysis will be performed with a 95% confidence interval, meaning that those whose P is \<0.05 will be considered significant values.

Conditions

  • Lateral Epicondylitis
  • Tennis Elbow

Interventions

COMBINATION_PRODUCT

Vitamin C

Will apply 1000mg of vitamin C, TENS and manual therapy. One session will be held per week for 6 weeks.

COMBINATION_PRODUCT

spinal manipulation

Applied spinal manipulations, tens and manual therapy.One session will be held per week for 6 weeks.

COMBINATION_PRODUCT

Transcutaneous electrical nerve stimulation (TENS)

Received a manual therapy intervention and Tens. one session will be held per week for 6 weeks.

Sponsors & Collaborators

  • Universidad Rey Juan Carlos

    lead OTHER

Principal Investigators

  • Ana I de la Llave Rincón · Universidad Rey Juan Carlos

  • José J Arias Buría · Universidad Rey Juan Carlos

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-21
Primary Completion
2021-01-22
Completion
2021-03-11

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04445727 on ClinicalTrials.gov